M Sue O'Dorisio

Title: M Sue O'Dorisio: Innovator in Somatostatin Research

Introduction

M Sue O'Dorisio is a notable inventor based in Columbus, OH, recognized for his contributions to the field of medical research, particularly in the area of somatostatin analogs. With a total of two patents to his name, O'Dorisio has made significant strides in developing methods for diagnosing and treating diseases associated with somatostatin receptors.

Latest Patents

O'Dorisio's latest patents include innovative approaches to the diagnosis and treatment of conditions such as cancer and acromegaly. One of his patents focuses on multi-tyrosinated somatostatin analogs, which are designed to target somatostatin receptors that are aberrantly expressed in certain diseases. This invention outlines methods and compositions that can aid in the diagnosis and treatment of these conditions. Another significant patent involves the application of peptide/cell receptor kinetics utilizing radiolabeled somatostatin congeners. This method allows for the detection and differentiation of neoplastic tissue in patients suspected of having tumors, enhancing the accuracy of cancer diagnostics.

Career Highlights

Throughout his career, O'Dorisio has been affiliated with prestigious institutions such as The Ohio State University and Louisiana State University and Agricultural & Mechanical College. His work has contributed to advancements in medical research and has had a lasting impact on the field.

Collaborations

O'Dorisio has collaborated with esteemed colleagues, including Eugene A Woltering and Thomas M O'Dorisio, further enriching his research endeavors and expanding the scope of his innovations.

Conclusion

M Sue O'Dorisio's contributions to somatostatin research exemplify the importance of innovation in medical science. His patents not only advance diagnostic methods but also pave the way for improved treatment options for patients with serious health conditions.